BRIAN HIGGINS,BRIAN LESTINI,FEI SU,KAPIL DHINGRA,KATHRYN E. PACKMAN,KENNETH KOLINSKY,RICHARD J. LEE
申请号：
BR112013003530
公开号：
BR112013003530A2
申请日:
2011.08.16
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
